Recent Updates
Recently added Catalysts
SMTI Positive Sentiment

Evaluation of Microbicidal Efficacy of BIASURGE® Advanced Surgical Solution

Thursday, March 7, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: This study evaluates the microbicidal efficacy of BIASURGE Advanced Surgical Solution against 18 microorganisms over 24 hours. It also includes a 28-day preservative challenge as per USP <51>. The findings indicate strong efficacy, with detailed methodology and implications discussed.
Price reaction · baseline $36.79 (2024-03-06 close) · hit pre-market · clean, no other SMTI news in the window
day 0 close · peak
+0.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Demonstrated microbicidal efficacy against 18 microorganisms.
  • Successful results over a 24-hour period.
  • Comprehensive evaluation including USP <51> preservative challenge.

Full Press Release Details

Authors : Larry Estlack, Rebecca McMahon, PhD, Nina Bionda, PhD
This research study presents the results of a series of studies conducted to evaluate the microbicidal efficacy of BIASURGE Advanced Surgical Solution against a panel of 18 microorganisms over a 24-hour period, as well as USP <51> preservative challenge over the course of 28 days. The research methodology, results, and implications are discussed in detail.

Frequently Asked Questions

What microorganisms were tested in the study?

The study evaluated BIASURGE against a panel of 18 microorganisms.

How long was the microbicidal efficacy tested?

The microbicidal efficacy was tested over a 24-hour period.

What does USP <51> refer to in the study?

USP <51> refers to the preservative challenge conducted over 28 days.

Who conducted the research study?

The study was conducted by Larry Estlack, Rebecca McMahon, PhD, and Nina Bionda, PhD.

ShareAdd on Google
Tags: SMTI Viatris Investor Conferences Healthcare BIASURGE microbicidal efficacy surgical solution microorganisms USP <51>
Last updated: Mar 7, 2024

Biotech snapshot

Cash runway
$29M liquidity · $0M/mo burn
Low dilution risk